<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1346" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1346/" /><meta name="ncbi_pagename" content="Coffin-Lowry Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Coffin-Lowry Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Coffin-Lowry Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/02/01" /><meta name="citation_author" content="R Curtis Rogers" /><meta name="citation_author" content="Fatima E Abidi" /><meta name="citation_pmid" content="20301520" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1346/" /><meta name="citation_keywords" content="Ribosomal protein S6 kinase alpha-3" /><meta name="citation_keywords" content="RPS6KA3" /><meta name="citation_keywords" content="Coffin-Lowry Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Coffin-Lowry Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="R Curtis Rogers" /><meta name="DC.Contributor" content="Fatima E Abidi" /><meta name="DC.Date" content="2018/02/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1346/" /><meta name="description" content="Coffin-Lowry syndrome (CLS) is usually characterized by severe-to-profound intellectual disability in males; less severely impaired individuals have been reported. Neuropsychiatric concerns can include behavioral problems, loss of strength, progressive spasticity or paraplegia, sleep apnea, or stroke. Stimulus-induced drop attacks (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of affected individuals. Typically SIDAs begin between mid-childhood and the teens. Characteristic facial features may be more apparent with age. Upper-extremity differences may be subtle and include short, soft, fleshy hands with tapered fingers as well as fleshy forearms. Progressive kyphoscoliosis is one of the most difficult aspects of long-term care. Affected females tend to have intellectual disability in the mild to moderate range and may also have the typical facial, hand, and skeletal findings noted in males." /><meta name="og:title" content="Coffin-Lowry Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Coffin-Lowry syndrome (CLS) is usually characterized by severe-to-profound intellectual disability in males; less severely impaired individuals have been reported. Neuropsychiatric concerns can include behavioral problems, loss of strength, progressive spasticity or paraplegia, sleep apnea, or stroke. Stimulus-induced drop attacks (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of affected individuals. Typically SIDAs begin between mid-childhood and the teens. Characteristic facial features may be more apparent with age. Upper-extremity differences may be subtle and include short, soft, fleshy hands with tapered fingers as well as fleshy forearms. Progressive kyphoscoliosis is one of the most difficult aspects of long-term care. Affected females tend to have intellectual disability in the mild to moderate range and may also have the typical facial, hand, and skeletal findings noted in males." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1346/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cls/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1346/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88079DE041597100000000023C00D0.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1346_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1346_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cockayne/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/coffin-siris/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1346_"><span class="title" itemprop="name">Coffin-Lowry Syndrome</span></h1><p class="contrib-group"><span itemprop="author">R Curtis Rogers</span>, MD and <span itemprop="author">Fatima E Abidi</span>, PhD, DABMGG.</p><a data-jig="ncbitoggler" href="#__NBK1346_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1346_ai__"><div class="contrib half_rhythm"><span itemprop="author">R Curtis Rogers</span>, MD<div class="affiliation small">Senior Clinical Geneticist, Greenwood Genetic Center<br />Greenville, South Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cgg@sregorc" class="oemail">gro.cgg@sregorc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Fatima E Abidi</span>, PhD, DABMGG<div class="affiliation small">Assistant Director, Molecular Diagnostic Laboratory<br />Greenwood Genetic Center<br />Greenwood, South Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cgg@idibaamitaf" class="oemail">gro.cgg@idibaamitaf</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 16, 2002</span>; Last Update: <span itemprop="dateModified">February 1, 2018</span>.</p><p><em>Estimated reading time: 28 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cls.Summary" itemprop="description"><h2 id="_cls_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Coffin-Lowry syndrome (CLS) is usually characterized by severe-to-profound intellectual disability in males; less severely impaired individuals have been reported. Neuropsychiatric concerns can include behavioral problems, loss of strength, progressive spasticity or paraplegia, sleep apnea, or stroke. Stimulus-induced drop attacks (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Typically SIDAs begin between mid-childhood and the teens. Characteristic facial features may be more apparent with age. Upper-extremity differences may be subtle and include short, soft, fleshy hands with tapered fingers as well as fleshy forearms. Progressive kyphoscoliosis is one of the most difficult aspects of long-term care. Affected females tend to have intellectual disability in the mild to moderate range and may also have the typical facial, hand, and skeletal findings noted in males.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CLS is established in males with the identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RPS6KA3.</i> The diagnosis of CLS is usually established in a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variant in <i>RPS6KA3</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Genetic mechanisms other than skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> in a heterozygous female (e.g., <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>RPS6KA3</i> pathogenic variants or whole or partial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one X chromosome in a female with an <i>RPS6KA3</i> pathogenic variant on her other X chromosome) have been reported. Careful examination of an intellectually normal female relative of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may reveal mild facial and/or hand manifestations.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> SIDAs are treated with medications such as clonazepam, valproate, selective serotonin reuptake inhibitors, or benzodiazepines; trials with different medications with efforts to optimize the dosage may be needed to improve outcome. Individuals who experience frequent SIDAs may require use of a protective helmet or a wheelchair and should be protected, if possible, from being startled. Risperidone may be of benefit to individuals who display destructive or self-injurious behavior. Feeding difficulties, abnormal growth velocity, behavioral problems, kyphoscoliosis, and obesity (if present) are treated in a standard manner.</p><p><i>Prevention of secondary complications:</i> Intervention to prevent progression of kyphoscoliosis to the point of cardiorespiratory compromise.</p><p><i>Surveillance:</i> Periodic hearing, dental, and vision examinations; annual clinical cardiac examination, adding an echocardiogram every five to ten years; regular monitoring of the spine for progressive kyphoscoliosis.</p><p><i>Agents/circumstances to avoid:</i> Individuals who experience SIDAs should be protected as much as possible from being startled and/or from falls.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CLS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. Approximately 70%-80% of probands have no family history of CLS, and 20%-30% have more than one additional <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. Children of a woman known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> are at 50% risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be heterozygous and at high risk for at least some developmental delay and mild physical signs of CLS. Molecular genetic testing for at-risk female relatives and prenatal testing for pregnancies at increased risk are possible in families in which the pathogenic variant has been identified in an affected family member.</p></div></div><div id="cls.Diagnosis"><h2 id="_cls_Diagnosis_">Diagnosis</h2><p>Coffin-Lowry syndrome is an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability disorder. Individuals recognized to have this disorder are typically male, although <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females have also been reported. There are no formal diagnostic criteria.</p><div id="cls.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Coffin-Lowry syndrome (CLS) <b>should be suspected in a male</b> with the following findings:</p><ul><li class="half_rhythm"><div><b>Developmental delay / intellectual disability.</b> Affected males typically have moderate-to-severe intellectual disability; since the advent of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, more mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males are being identified [<a class="bk_pop" href="#cls.REF.field.2006.509">Field et al 2006</a>].</div></li><li class="half_rhythm"><div><b>Characteristic craniofacial features</b> (particularly in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> older child or adult; see <a class="figpopup" href="/books/NBK1346/figure/cls.F1/?report=objectonly" target="object" rid-figpopup="figclsF1" rid-ob="figobclsF1">Figure 1</a>, <a class="figpopup" href="/books/NBK1346/figure/cls.F2/?report=objectonly" target="object" rid-figpopup="figclsF2" rid-ob="figobclsF2">Figure 2</a>, and <a class="figpopup" href="/books/NBK1346/figure/cls.F3/?report=objectonly" target="object" rid-figpopup="figclsF3" rid-ob="figobclsF3">Figure 3</a>):</div><ul><li class="half_rhythm"><div>Usually prominent forehead and supraorbital ridges with thick eyebrows</div></li><li class="half_rhythm"><div>Usually marked widely spaced eyes with downslanted palpebral fissures; occasionally, relatively normal periorbital region with mild telecanthus</div></li><li class="half_rhythm"><div>Consistent, often striking, nasal findings including depressed bridge, blunt tip, and thick alae nasi and septum, resulting in small nares</div></li><li class="half_rhythm"><div>Wide mouth, usually held open; thick vermilion of the upper and lower lips with everted vermilion of the lower lip</div></li><li class="half_rhythm"><div>Coarse facial appearance in childhood with progression to a more "pugilistic" look with age</div></li><li class="half_rhythm"><div>Prominent ears</div></li></ul></li><li class="half_rhythm"><div><b>Upper extremity differences</b></div><ul><li class="half_rhythm"><div>Short, soft, fleshy hands, often with remarkably hyperextensible fingers, and a short horizontal palmar crease across the hypothenar area</div></li><li class="half_rhythm"><div>Fingers that taper markedly from relatively wide proximally to narrow distally, with small terminal phalanges and nails (see <a class="figpopup" href="/books/NBK1346/figure/cls.F4/?report=objectonly" target="object" rid-figpopup="figclsF4" rid-ob="figobclsF4">Figure 4</a>). The differences in the hands may sometimes be subtle (see <a class="figpopup" href="/books/NBK1346/figure/cls.F5/?report=objectonly" target="object" rid-figpopup="figclsF5" rid-ob="figobclsF5">Figure 5</a>).</div></li><li class="half_rhythm"><div>Soft, malleable hands with an almost "plush-cushion" feel to the palm, as may be seen in an obese individual</div></li><li class="half_rhythm"><div>Full, fleshy forearms: a potentially useful sign in diagnosing a younger child</div></li></ul></li><li class="half_rhythm"><div><b>Musculoskeletal features</b></div><ul><li class="half_rhythm"><div>Frequent pectus carinatum and/or excavatum</div></li><li class="half_rhythm"><div>Childhood onset of kyphoscoliosis that is often progressive</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figclsF1" co-legend-rid="figlgndclsF1"><a href="/books/NBK1346/figure/cls.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figclsF1" rid-ob="figobclsF1"><img class="small-thumb" src="/books/NBK1346/bin/cls-Image001.gif" src-large="/books/NBK1346/bin/cls-Image001.jpg" alt="Figure 1. . AP view of a boy age two years with CLS showing relatively fine facial features but with widely spaced eyes, mildly downslanted palpebral fissures, short nose with broad columella, and thick, slightly everted vermilion of the lips (Affected individual has a known RPS6KA3 pathogenic variant." /></a><div class="icnblk_cntnt" id="figlgndclsF1"><h4 id="cls.F1"><a href="/books/NBK1346/figure/cls.F1/?report=objectonly" target="object" rid-ob="figobclsF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">AP view of a boy age two years with CLS showing relatively fine facial features but with widely spaced eyes, mildly downslanted palpebral fissures, short nose with broad columella, and thick, slightly everted vermilion of the lips (Affected individual <a href="/books/NBK1346/figure/cls.F1/?report=objectonly" target="object" rid-ob="figobclsF1">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figclsF2" co-legend-rid="figlgndclsF2"><a href="/books/NBK1346/figure/cls.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figclsF2" rid-ob="figobclsF2"><img class="small-thumb" src="/books/NBK1346/bin/cls-Image002.gif" src-large="/books/NBK1346/bin/cls-Image002.jpg" alt="Figure 2. . AP and lateral view of the same boy in Figure 1 at age five years, showing a more triangular-shaped face, increasing coarseness, and expression of the typical facial signs of CLS (Affected individual has a known RPS6KA3 pathogenic variant." /></a><div class="icnblk_cntnt" id="figlgndclsF2"><h4 id="cls.F2"><a href="/books/NBK1346/figure/cls.F2/?report=objectonly" target="object" rid-ob="figobclsF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">AP and lateral view of the same boy in Figure 1 at age five years, showing a more triangular-shaped face, increasing coarseness, and expression of the typical facial signs of CLS (Affected individual has a known <i>RPS6KA3</i> pathogenic variant.) </p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figclsF3" co-legend-rid="figlgndclsF3"><a href="/books/NBK1346/figure/cls.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figclsF3" rid-ob="figobclsF3"><img class="small-thumb" src="/books/NBK1346/bin/cls-Image003.gif" src-large="/books/NBK1346/bin/cls-Image003.jpg" alt="Figure 3. . AP view of an adolescent showing relatively mild facial signs but with widely spaced eyes, mildly downslanted palpebral fissures, thick vermilion of the upper and lower lips, and small teeth." /></a><div class="icnblk_cntnt" id="figlgndclsF3"><h4 id="cls.F3"><a href="/books/NBK1346/figure/cls.F3/?report=objectonly" target="object" rid-ob="figobclsF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">AP view of an adolescent showing relatively mild facial signs but with widely spaced eyes, mildly downslanted palpebral fissures, thick vermilion of the upper and lower lips, and small teeth. The columnella is broad but nares are a good size, perhaps <a href="/books/NBK1346/figure/cls.F3/?report=objectonly" target="object" rid-ob="figobclsF3">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figclsF4" co-legend-rid="figlgndclsF4"><a href="/books/NBK1346/figure/cls.F4/?report=objectonly" target="object" title="Figure 4. " class="img_link icnblk_img figpopup" rid-figpopup="figclsF4" rid-ob="figobclsF4"><img class="small-thumb" src="/books/NBK1346/bin/cls-Image004.gif" src-large="/books/NBK1346/bin/cls-Image004.jpg" alt="Figure 4. " /></a><div class="icnblk_cntnt" id="figlgndclsF4"><h4 id="cls.F4"><a href="/books/NBK1346/figure/cls.F4/?report=objectonly" target="object" rid-ob="figobclsF4">Figure 4. </a></h4><p class="float-caption no_bottom_margin">Hand of the child illustrated in Figure 1 and Figure 2 A. At age two years</p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figclsF5" co-legend-rid="figlgndclsF5"><a href="/books/NBK1346/figure/cls.F5/?report=objectonly" target="object" title="Figure 5" class="img_link icnblk_img figpopup" rid-figpopup="figclsF5" rid-ob="figobclsF5"><img class="small-thumb" src="/books/NBK1346/bin/cls-Image005.gif" src-large="/books/NBK1346/bin/cls-Image005.jpg" alt="Figure 5. A." /></a><div class="icnblk_cntnt" id="figlgndclsF5"><h4 id="cls.F5"><a href="/books/NBK1346/figure/cls.F5/?report=objectonly" target="object" rid-ob="figobclsF5">Figure 5</a></h4><p class="float-caption no_bottom_margin">A. Hand of an older child showing classic tapering and soft appearance B. More subtle differences seen in the hand of the individual illustrated in Figure 3</p></div></div><p>Note: Several authors have stated that the diagnosis may be difficult in the young child. Indeed, more than in most syndromes, the facial characteristics of CLS become increasingly discernible with age. However, even in neonates, the diagnosis of CLS is most often apparent if considered.</p><p><b>Radiographic findings</b> in CLS are nonspecific individually or as a pattern but may be helpful when the diagnosis is suspected [<a class="bk_pop" href="#cls.REF.hanauer.2002.705">Hanauer &#x00026; Young 2002</a>]:</p><ul><li class="half_rhythm"><div>Thickened skull with large frontal sinuses</div></li><li class="half_rhythm"><div>Anterior beaking of the vertebrae with narrow disc spaces and related degenerative vertebral changes</div></li><li class="half_rhythm"><div>Kyphoscoliosis</div></li><li class="half_rhythm"><div>Narrow pelvis</div></li><li class="half_rhythm"><div>Metacarpal pseudoepiphyses, poor modeling of the middle phalanges, and tufting of the distal phalanges (Metacarpophalangeal profiles do not appear to aid diagnosis.)</div></li><li class="half_rhythm"><div>In some individuals, mild cerebral atrophy, hypoplasia of corpus callosum, periventricular white matter changes in parietal and frontal lobes, and/or compression of the foramen magnum on cranial MRI [<a class="bk_pop" href="#cls.REF.tos.2015.47">Tos et al 2015</a>, <a class="bk_pop" href="#cls.REF.upadia.2017.1087">Upadia et al 2017</a>]</div></li></ul><p>CLS <b>should be suspected in a female</b> with any of the characteristics listed as <a href="#cls.Suggestive_Findings">raising suspicion in males</a>.</p><ul><li class="half_rhythm"><div>Females with full manifestation (including mild-to-moderate intellectual disability with typical facial, hand, and skeletal findings) have been reported [<a class="bk_pop" href="#cls.REF.young.1988.344">Young 1988</a>, <a class="bk_pop" href="#cls.REF.plomp.1995.259">Plomp et al 1995</a>, <a class="bk_pop" href="#cls.REF.fryssira.2002.405">Fryssira et al 2002</a>, <a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>, <a class="bk_pop" href="#cls.REF.jurkiewicz.2010.268">Jurkiewicz et al 2010</a>].</div></li><li class="half_rhythm"><div>Careful examination of an intellectually normal female relative of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may reveal mild facial and/or hand manifestations.</div></li></ul></div><div id="cls.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of CLS <b>is established in a male proband</b> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RPS6KA3</i> (also known as <i>RSK2</i>) on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1346/table/cls.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figclsTmoleculargenetictestingusedin" rid-ob="figobclsTmoleculargenetictestingusedin">Table 1</a>).</p><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of CLS <b>is usually established in a female proband</b> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RPS6KA3</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1346/table/cls.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figclsTmoleculargenetictestingusedin" rid-ob="figobclsTmoleculargenetictestingusedin">Table 1</a>). Genetic mechanisms other than skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> in a heterozygous female (e.g., <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>RPS6KA3</i> pathogenic variants or whole or partial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one X chromosome in a female with a <i>RPS6KA3</i> pathogenic variant on her other X chromosome) have been reported [<a class="bk_pop" href="#cls.REF.jacquot.2002.2">Jacquot et al 2002</a>].</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>RPS6KA3</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>RPS6KA3</i> and other genes of interest (see <a href="#cls.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="cls.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Coffin-Lowry Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1346/table/cls.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cls.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>RPS6KA3</i></td><td headers="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4,&#x000a0;5</sup></td><td headers="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-95%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-10%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td><td headers="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_cls.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cls.TF.1.1"><p class="no_margin">See <a href="/books/NBK1346/#cls.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cls.TF.1.2"><p class="no_margin">See <a href="#cls.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cls.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cls.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="cls.TF.1.5"><p class="no_margin">Note: <a class="bk_pop" href="#cls.REF.schneider.2013.150">Schneider et al [2013]</a> identified a deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that results in an aberrant protein that would not be detected by routine sequencing of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> region.</p></div></dd><dt>6. </dt><dd><div id="cls.TF.1.6"><p class="no_margin"><a href="http://www.hgmd.cf.ac.uk/ac/index.php" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Gene Mutation Database</a>, <a class="bk_pop" href="#cls.REF.delaunoy.2001.103">Delaunoy et al [2001]</a>, <a class="bk_pop" href="#cls.REF.delaunoy.2006.161">Delaunoy et al [2006]</a></p></div></dd><dt>7. </dt><dd><div id="cls.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="cls.Clinical_Characteristics"><h2 id="_cls_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cls.Clinical_Description"><h3>Clinical Description</h3><p>Individuals recognized to have this disorder are typically male, although <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females have also been reported. Such females have findings that range from severe (as seen in males) to very mild. As more individuals (both male and female) are identified through molecular testing prior to a suspected clinical diagnosis, milder manifestations are being recognized.</p><p><a class="bk_pop" href="#cls.REF.manouvrierhanu.1999.775">Manouvrier-Hanu et al [1999]</a> reported two sibs with an unusually mild presentation associated with a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant. The authors are aware of an individual with a proven <i>RPS6KA3</i> pathogenic missense variant who is able to work in a fast-food restaurant [C Skinner, personal communication].</p><p><b>Age at diagnosis</b> is variable based on the physical features and availability of testing.</p><div id="cls.Development"><h4>Development</h4><p>Coffin-Lowry syndrome (CLS) is typically characterized by severe-to-profound intellectual disability in males, although those with mild disability have been reported [<a class="bk_pop" href="#cls.REF.young.1988.344">Young 1988</a>, <a class="bk_pop" href="#cls.REF.hanauer.2002.705">Hanauer &#x00026; Young 2002</a>, <a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>, <a class="bk_pop" href="#cls.REF.pereira.2010.627">Pereira et al 2010</a>]. Affected females tend to have intellectual disability in the mild to moderate range.</p><ul><li class="half_rhythm"><div>Early developmental assessments may overestimate the ultimate developmental prognosis [<a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>]. Early milestones are variably delayed with speech typically more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> than motor development.</div></li><li class="half_rhythm"><div>Due to hypotonia, individuals may present early in life with feeding problems.</div></li></ul></div><div id="cls.Neuropsychiatric"><h4>Neuropsychiatric</h4><p>Individuals with CLS are often described as generally happy and easygoing, although self-injury and other behavioral problems have been reported.</p><p>Detailed neurologic assessment may be hampered by the severe intellectual disability. Findings reported include the following:</p><ul><li class="half_rhythm"><div>Loss of strength and muscle mass</div></li><li class="half_rhythm"><div>Both decreased and increased deep tendon reflexes</div></li><li class="half_rhythm"><div>Sleep apnea</div></li><li class="half_rhythm"><div>Stroke</div></li><li class="half_rhythm"><div>Progressive spasticity</div></li><li class="half_rhythm"><div>Progressive paraplegia with loss of the ability to walk (ascribed to both calcification of the ligamenta flava and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> stenosis of the spinal canal [<a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>])</div></li><li class="half_rhythm"><div>Stimulus-induced drop attacks (SIDAs) that occur when unexpected tactile or auditory stimuli or excitement triggers a 60- to 80-millisecond electromyographic silence in the lower limbs, resulting in a brief collapse (though no loss of consciousness) [<a class="bk_pop" href="#cls.REF.crow.1998.94">Crow et al 1998</a>, <a class="bk_pop" href="#cls.REF.nakamura.1998.148">Nakamura et al 1998</a>, <a class="bk_pop" href="#cls.REF.hahn.2012.335">Hahn &#x00026; Hanauer 2012</a>]:</div><ul><li class="half_rhythm"><div>See <a class="bk_pop" href="#cls.REF.nelson.2003.e197">Nelson &#x00026; Hahn [2003]</a> for a video illustration of SIDAs.</div></li><li class="half_rhythm"><div>Onset occurs between ages four and 17 years and a mean age at onset of 8.6 years [<a class="bk_pop" href="#cls.REF.nakamura.2005.114">Nakamura et al 2005</a>].</div></li><li class="half_rhythm"><div>SIDAs were reported in 20% (34/170) of individuals in the CLS Foundation database [<a class="bk_pop" href="#cls.REF.stephenson.2005.108">Stephenson et al 2005</a>].</div></li></ul></li></ul><p><b>Changes with age.</b>
<a class="bk_pop" href="#cls.REF.stephenson.2005.108">Stephenson et al [2005]</a> have also emphasized that the nature of the movement disorder may change with age and that a single individual may have more than one type of neurologic sign. The range of manifestations include cataplexy that varies with the stimulus, hyperekplexia, a prolonged tonic reaction, and true epileptic seizures. Epileptic seizures affect approximately 5% of individuals with CLS [<a class="bk_pop" href="#cls.REF.stephenson.2005.108">Stephenson et al 2005</a>].</p></div><div id="cls.Typical_Physical_Characteristics"><h4>Typical Physical Characteristics</h4><p>See also <a href="#cls.Suggestive_Findings">Suggestive Findings</a>.</p><p><b>Craniofacial.</b> Characteristic craniofacial features (see <a class="figpopup" href="/books/NBK1346/figure/cls.F1/?report=objectonly" target="object" rid-figpopup="figclsF1" rid-ob="figobclsF1">Figure 1</a>, <a class="figpopup" href="/books/NBK1346/figure/cls.F2/?report=objectonly" target="object" rid-figpopup="figclsF2" rid-ob="figobclsF2">Figure 2</a>, and <a class="figpopup" href="/books/NBK1346/figure/cls.F3/?report=objectonly" target="object" rid-figpopup="figclsF3" rid-ob="figobclsF3">Figure 3</a>) may be more apparent with age.</p><p><b>Upper-extremity</b> differences may be subtle. These include short, soft, fleshy hands with tapered fingers as well as fleshy forearms.</p><p><b>Musculoskeletal.</b> Progressive kyphoscoliosis is one of the most difficult aspects of the long-term care of individuals with CLS. The precise prevalence is not known, but at least 47% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and 32% of females have been reported to have progressive kyphoscoliosis [<a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>]. The rates were higher in a series reported from an orthopedic referral clinic [<a class="bk_pop" href="#cls.REF.herrerasoto.2007.85">Herrera-Soto et al 2007</a>]. Although no accepted definition of severity has been adopted in published reports, it is clear that the severity often progresses over time and that respiratory compromise caused by kyphoscoliosis may contribute to premature death.</p><p>Sternal deformation in the form of pectus carinatum and/or excavatum frequently occurs.</p><p>Other minor skeletal changes that may be seen on radiographs are of no clinical consequence.</p><p><b>Cardiovascular.</b> Approximately 14% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and 5% of affected females have cardiovascular disorders [<a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>]. These percentages may be underestimates as many individuals with CLS have not had thorough initial or ongoing cardiac assessment. Reports have included: abnormalities of the mitral, tricuspid, and aortic valves; short chordae; cardiomyopathy (in one individual, with endocardial fibroelastosis); unexplained congestive heart failure; and dilatation of the aorta and of the pulmonary artery [reviewed in <a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>]. An individual reported by <a class="bk_pop" href="#cls.REF.facher.2004.176">Facher et al [2004]</a> had a restrictive cardiomyopathy. <a class="bk_pop" href="#cls.REF.martinez.2011.3030">Martinez et al [2011]</a> reported an individual with CLS who had left ventricular non-compaction cardiomyopathy with a restrictive pattern. Cardiac anomalies may contribute to premature death. There has not been a systematic review of cardiovascular disorders in individuals with CLS.</p><p><b>Growth.</b> Prenatal growth is normal; growth failure usually occurs early in the postnatal period. Males and severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females generally fall below the third centile in height but are expected to track a curve. The reduced height may reflect disproportionately short lower limbs [<a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>, <a class="bk_pop" href="#cls.REF.touraine.2002.179">Touraine et al 2002</a>]. While microcephaly is common, many individuals with CLS have a normal head circumference.</p><p><b>Dental.</b> Dental anomalies are common and include small teeth, malpositioning, open bite, hypodontia of secondary teeth, advanced or delayed eruption of primary teeth, and premature loss that appears to have more than one cause. The palate is high. With age, the retrognathia in the younger child tends to be replaced by prognathism.</p><p><b>Hearing loss</b> is reported in 30% [<a class="bk_pop" href="#cls.REF.pereira.2010.627">Pereira et al 2010</a>]. Hunter reported hearing loss in 14/89 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and 1/22 affected females [<a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>].</p><ul><li class="half_rhythm"><div>An audiogram may reveal sensorineural hearing loss.</div></li><li class="half_rhythm"><div>Malformation of the labyrinth has been reported, as has late onset of hearing loss [<a class="bk_pop" href="#cls.REF.rosanowski.1998.224">Rosanowski et al 1998</a>].</div></li><li class="half_rhythm"><div>Clustering of hearing loss within families may occur.</div></li></ul><p><b>Vision problems.</b> Significant visual problems appear to be uncommon, although cataract, retinal pigment atrophy, and optic atrophy have been reported and the incidence of chronic eyelid irritation (blepharitis) may be increased [reviewed in <a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>].</p><p><b>Neuroimaging studies</b> have not demonstrated a consistent pattern of brain abnormality, but the following findings have been reported [<a class="bk_pop" href="#cls.REF.tos.2015.47">Tos et al 2015</a>, <a class="bk_pop" href="#cls.REF.upadia.2017.1087">Upadia et al 2017</a>]:</p><ul><li class="half_rhythm"><div>Abnormalities of the corpus callosum including thinning and agenesis, reported by several authors [<a class="bk_pop" href="#cls.REF.kondoh.1998.59">Kondoh et al 1998</a>, <a class="bk_pop" href="#cls.REF.wang.2006.1274">Wang et al 2006</a>].</div></li><li class="half_rhythm"><div>Multiple focal frontal hypodensities visible on MRI [<a class="bk_pop" href="#cls.REF.kondoh.1998.59">Kondoh et al 1998</a>]. Hypodensities attributed to focal areas of CSF were reported in three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs by <a class="bk_pop" href="#cls.REF.wang.2006.1274">Wang et al [2006]</a>; they also showed thinning of the corpus callosum, vermian hypoplasia, and mild ventricular asymmetry. The authors concluded that the degree of intellectual disability correlated with the severity of the MRI findings.</div></li><li class="half_rhythm"><div>Periventricular white matter abnormalities</div></li><li class="half_rhythm"><div>Constricted foramen magnum (decreased diameter)</div></li><li class="half_rhythm"><div>Reduced gray- and white-matter volume without evidence of ventriculomegaly <i>ex vacuo</i> on quantitative MRI in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and females, suggesting an early neurodevelopmental abnormality such as reduced cellular proliferation [<a class="bk_pop" href="#cls.REF.kesler.2007.143">Kesler et al 2007</a>]</div></li></ul><p><b>Neuropathology.</b> Abnormal gyration and lamination have been noted at autopsy [<a class="bk_pop" href="#cls.REF.coffin.2003.187">Coffin 2003</a>].</p><p><b>Other.</b> Findings reported in single individuals include rectal prolapse, uterine prolapse, jejunal diverticuli, colonic diverticuli with reduced ganglion cells, popliteal ganglion, pyloric stenosis, unilateral renal agenesis, anteriorly placed anus, increased facial pigment, and enlarged trachea [reviewed in <a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>].</p><p><b>Mortality.</b> Life span is reduced in some individuals with CLS. Of individuals reported in the literature, death occurred in 13.5% of males and 4.5% of females at a mean age of 20.5 (range: 13-34) years [<a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>].</p><ul><li class="half_rhythm"><div>Complicating factors have included cardiac anomalies, panacinar emphysema, respiratory complications, progressive kyphoscoliosis, and seizure-associated aspiration.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#cls.REF.coffin.2003.187">Coffin [2003]</a> reported that one of his original patients died at age 18.8 years of pneumonia superimposed on chronic lung and heart disease, and a second individual died at age 18 years of acute food aspiration.</div></li><li class="half_rhythm"><div>The authors are aware of an individual with CLS who had life-threatening central and obstructive sleep apnea, and of another male who had a history of chronic obstructive and central sleep apnea who died from respiratory complications after surgery for jaw advancement.</div></li><li class="half_rhythm"><div>One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male and one <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> female died of Hodgkin disease [reviewed in <a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>].</div></li></ul></div></div><div id="cls.Heterozygous_Females"><h3>Heterozygous Females</h3><p>Heterozygous females show markedly variable phenotypes with mild facial coarsening, tapering fingers, short stature, normal intelligence, or varied degrees of intellectual disability. Such individuals may have a higher rate of psychiatric illness than that found in the general population. Six (8.8%) of 68 women (22 females with CLS, 38 unaffected heterozygotes, and 8 "<a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>" sisters) have had psychiatric diagnoses, including schizophrenia, bipolar disease, and "psychosis" [reviewed in <a class="bk_pop" href="#cls.REF.hunter.2002.345">Hunter 2002</a>]. One of two women studied by <a class="bk_pop" href="#cls.REF.micheli.2007.35">Micheli et al [2007]</a> was described as having a "psychosis" and one of two affected sisters reported by <a class="bk_pop" href="#cls.REF.wang.2006.1274">Wang et al [2006]</a> as having schizophrenia.</p></div><div id="cls.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Although no strong correlation exists between <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and location or type of <i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, individuals with certain <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants may tend to have milder disease expression [<a class="bk_pop" href="#cls.REF.delaunoy.2001.103">Delaunoy et al 2001</a>]. The family classified as having a form of nonsyndromic intellectual disability (MRX19; see <a href="#cls.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>) had a missense variant in <i>RPS6KA3</i>, which caused an 80% reduction in ribosomal S6 kinase enzyme activity, in contrast to most pathogenic variants in individuals with CLS, which cause a total loss of ribosomal S6 kinase enzyme activity [<a class="bk_pop" href="#cls.REF.merienne.1999.13">Merienne et al 1999</a>]. This finding indicates that some <i>RPS6KA3</i> variants probably give rise to non-CLS phenotypes or nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability.</p><p><a class="bk_pop" href="#cls.REF.nakamura.2005.114">Nakamura et al [2005]</a> suggested that truncating variants, either in or upstream from the N-terminal kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, may cause a particular susceptibility to stimulus-induced drop attacks (SIDAs). However, the finding of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female with SIDAs who has a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the region encoding the C-terminal kinase domain of the protein would argue against this correlation [<a class="bk_pop" href="#cls.REF.rojnueangnit.2014.516">Rojnueangnit et al 2014</a>].</p></div><div id="cls.Nomenclature"><h3>Nomenclature</h3><p>Early authors referred to Coffin syndrome until it was recognized that the individuals reported by <a class="bk_pop" href="#cls.REF.lowry.1971.496">Lowry et al [1971]</a> had the same syndrome.</p><p>Some early texts and papers confused Coffin-Siris syndrome and CLS.</p></div><div id="cls.Prevalence"><h3>Prevalence</h3><p>No estimate of the prevalence of CLS has been published. Based on the authors' experience, a rate of 1:40,000 to 1:50,000 may be reasonable &#x02013; although it may underestimate the actual prevalence.</p></div></div><div id="cls.Genetically_Related_Allelic_Disorder"><h2 id="_cls_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><b>Nonsyndromic intellectual disability.</b> Two families have now been reported by <a class="bk_pop" href="#cls.REF.field.2006.509">Field et al [2006]</a> to have nonsyndromic intellectual disability associated with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RPS6KA3</i>.</p><p>One form of nonsyndromic intellectual disability (MRX19) has been shown to be caused by an <i>RPS6KA3</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant [<a class="bk_pop" href="#cls.REF.merienne.1999.13">Merienne et al 1999</a>]; another individual with a pathogenic missense variant and only mild intellectual disability was reported by <a class="bk_pop" href="#cls.REF.delaunoy.2001.103">Delaunoy et al [2001]</a>.</p></div><div id="cls.Differential_Diagnosis"><h2 id="_cls_Differential_Diagnosis_">Differential Diagnosis</h2><p>The diagnosis of Coffin-Lowry syndrome (CLS) in the older male child or adult is usually straightforward. The findings in a young child or more mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female may overlap with other syndromes:</p><ul><li class="half_rhythm"><div><b>Borjeson-Forssman-Lehmann syndrome</b> (BFLS; OMIM <a href="http://omim.org/entry/301900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">301900</a>) is an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder characterized by severe intellectual disability, hand findings similar to those of CLS, short nose with anteverted nares that may have a thick septum and small nares, and kyphoscoliosis. Additional findings are large, prominent ears and visual problems. Individuals with BFLS also have extreme hypogonadism and tend to have marked gynecomastia. Females may show partial expression of the syndrome. Absent findings are marked wide-spaced eyes, wide mouth, and thick vermilion of the lips. Pathogenic variants in <i>PHF6</i> are causative [<a class="bk_pop" href="#cls.REF.lower.2002.661">Lower et al 2002</a>].</div></li></ul><p>While CLS shares some facial findings with Williams syndrome, the genetically heterogeneous FG syndrome, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> alpha-thalassemia intellectual disability (ATRX) syndrome, and Pitt-Hopkins syndrome, none of these disorders shows the hand changes seen in CLS, and each has additional distinguishing features:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/williams/"><b>Williams syndrome</b></a> also includes cardiovascular disease (elastin arteriopathy, peripheral pulmonary stenosis, supravalvular aortic stenosis, hypertension), connective tissue abnormalities, intellectual disability (usually mild), a specific cognitive profile, unique personality characteristics, growth abnormalities, and endocrine abnormalities (hypercalcemia, hypercalciuria, hypothyroidism, and early puberty). Feeding difficulties often lead to failure to thrive in infancy. More than 99% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> of the Williams-Beuren syndrome <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> (WBSCR) that encompasses the elastin gene (<i>ELN</i>). Williams syndrome is transmitted in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most cases are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> occurrences.</div></li><li class="half_rhythm"><div><b>FG syndrome type 1</b> (see <a href="/books/n/gene/fg/"><i>MED12</i>-Related Disorders</a>) shares with CLS: <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance, intellectual disability, a broad forehead, widely spaced eyes with downslanted palpebral fissures, a thick vermilion of the lower lip, kyphoscoliosis, pectus excavatum, and characteristic behaviors. It is distinguished by its disproportionate macrocephaly; constipation that may be associated with anal anomalies; broad thumbs and halluces; prominent fingertip pads; and small, rounded, cupped ears that often have an overfolded superior helix [<a class="bk_pop" href="#cls.REF.graham.1998.145">Graham et al 1998</a>]. Hypotonia often evolves into joint restriction. Partial absence of the corpus callosum and fused mammillary bodies are relatively common.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/xlmr/"><b>Alpha-thalassemia X-linked intellectual disability (ATRX) syndrome</b></a> is characterized by distinctive craniofacial features, genital anomalies and severe developmental delays with hypotonia, intellectual disability, and mild-to-moderate anemia secondary to alpha-thalassemia. Genital anomalies range from hypospadias and undescended testes to severe hypospadias and ambiguous genitalia, to normal-appearing female genitalia in individuals with a 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>. ATRX syndrome is caused by pathogenic variants in <i>ATRX</i>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/pitt-hopkins/"><b>Pitt-Hopkins syndrome</b></a> is characterized by distinctive facial features that become more apparent with age, significant developmental delay / intellectual disability, and episodic hyperventilation and/or breath-holding while awake, which occurs in about half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Other common findings are behavioral issues, hand stereotypic movements, seizures, constipation, and severe myopia. Pitt-Hopkins syndrome is caused by <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of <i>TCF4</i> resulting from either a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TCF4</i> or a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region in which <i>TCF4</i> is located (18q21.2)</div></li></ul><p><b>Chromosome disorder.</b> Individuals with a variety of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> disorders may have features of Coffin-Lowry syndrome. Two examples:</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#cls.REF.mccandless.2000.93">McCandless et al [2000]</a> reported a family with del(10)(q25.1q25.3) in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members had findings suggestive of CLS.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#cls.REF.concannon.2002.e41">Concannon et al [2002]</a> reported an individual with features of CLS and a complex <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement (involving chromosomes 2,3,7, and 11).</div></li></ul></div><div id="cls.Management"><h2 id="_cls_Management_">Management</h2><div id="cls.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Coffin-Lowry syndrome (CLS), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Measurement of height, weight, and head circumference</div></li><li class="half_rhythm"><div>History and neurologic examination to assess for changes in gait or in bowel or bladder function and for epilepsy or movement disorder</div></li><li class="half_rhythm"><div>Developmental assessment and formulation of an intervention plan</div></li><li class="half_rhythm"><div>Complete musculoskeletal examination with particular attention to the chest and spine; radiographic assessment if clinically indicated</div></li><li class="half_rhythm"><div>Developmental, age-appropriate hearing assessment</div></li><li class="half_rhythm"><div>Dental evaluation</div></li><li class="half_rhythm"><div>Physical examination of the heart and ECG, with baseline echocardiogram</div></li><li class="half_rhythm"><div>Polysomnographic study to rule out obstructive sleep apnea</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation, including refraction and fundoscopy</div></li><li class="half_rhythm"><div>Evaluation of appropriate family members for signs of the condition</div></li><li class="half_rhythm"><div>Assessment of the family's capacity to care for the child, especially if mother is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> intellectually</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cls.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Individuals with CLS should be provided with every opportunity to develop communication skills and to participate in activities and self-care in order to develop a degree of independence.</p><p>Awareness of stimulus-induced drop attacks (SIDAs) should allow early intervention to minimize the occurrence of triggering stimuli and to provide protection from falls:</p><ul><li class="half_rhythm"><div>Trials with different medications and efforts to optimize the dosage may improve outcome [<a class="bk_pop" href="#cls.REF.oriordan.2006.109">O'Riordan et al 2006</a>, <a class="bk_pop" href="#cls.REF.arslan.2014.196">Arslan et al 2014</a>].</div><ul><li class="half_rhythm"><div>SIDAs were reduced in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> person treated with clonazepam [<a class="bk_pop" href="#cls.REF.arslan.2014.196">Arslan et al 2014</a>].</div></li><li class="half_rhythm"><div>A trial of antiepileptic drugs (AEDs) (e.g., valproate), or selective serotonin reuptake inhibitors may be indicated [<a class="bk_pop" href="#cls.REF.fryssira.2002.405">Fryssira et al 2002</a>], although generally they are not effective.</div></li><li class="half_rhythm"><div>Benzodiazepines, sometimes in increasing doses, have proved effective in some cases [<a class="bk_pop" href="#cls.REF.touraine.2002.179">Touraine et al 2002</a>, <a class="bk_pop" href="#cls.REF.nakamura.2005.114">Nakamura et al 2005</a>].</div></li><li class="half_rhythm"><div>In an individual who was not helped by a variety of medications, <a class="bk_pop" href="#cls.REF.havaligi.2007.373">Havaligi et al [2007]</a> reported a good response with sodium oxybate.</div></li><li class="half_rhythm"><div>Improvement of events occurred in a male after treatment of obstructive sleep apnea with tracheostomy [<a class="bk_pop" href="#cls.REF.imataka.2016.498">Imataka et al 2016</a>].</div></li></ul></li><li class="half_rhythm"><div>If attacks occur with great frequency a protective helmet may be indicated and use of a wheelchair may be required to prevent falling and injury.</div></li></ul><p>Risperidone may be of benefit to individuals who display destructive or self-injurious behavior [<a class="bk_pop" href="#cls.REF.valdovinos.2002.268">Valdovinos et al 2002</a>].</p><p>Feeding difficulties, abnormal growth velocity, and obesity, if present, should be assessed and treated in a standard manner.</p><p>Treatment of behavioral problems is standard and requires periodic reassessment.</p><p>Treatment of kyphoscoliosis is standard but requires reassessment well into adulthood.</p></div><div id="cls.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Early recognition of spinal problems such as kyphoscoliosis and stenosis may allow prevention of progression and/or intervention to prevent long-term cardiovascular or neurologic complications that may be life threatening.</p><p>Similarly, early recognition of some cardiac anomalies may allow prevention of secondary complications or prolongation of adequate function. Some individuals with CLS may require subacute bacterial endocarditis (SBE) prophylaxis.</p><p>Attention to vision and hearing may prevent some secondary behavioral changes. Identification and treatment of blepharitis may prevent eye rubbing and potential corneal damage.</p><p>Attention to dental hygiene and gum disease may reduce the risk of premature tooth loss.</p></div><div id="cls.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Periodic tests of hearing and vision</div></li><li class="half_rhythm"><div>Cardiac evaluation performed at diagnosis and annual physical cardiac examination thereafter. Even if initial echocardiogram is normal, it should be repeated every five to ten years in light of uncertainty as to the incidence and range in age of onset of cardiomyopathy [<a class="bk_pop" href="#cls.REF.massin.1999.468">Massin et al 1999</a>, <a class="bk_pop" href="#cls.REF.facher.2004.176">Facher et al 2004</a>].</div></li><li class="half_rhythm"><div>Monitoring of the spine for the development of progressive kyphoscoliosis. There should be a high index of suspicion for narrowing of the spinal canal with attention to change in gait and bowel/bladder habits, expression of pain, and focal neurologic changes such as clonus or abnormal tendon reflexes.</div></li><li class="half_rhythm"><div>Routine dental evaluation as in the general population but with particular attention to the risk of tooth loss</div></li></ul><p>Note: A table containing suggested guidelines for follow up of individuals with CLS is provided in <a class="bk_pop" href="#cls.REF.hunter.2010">Hunter [2010]</a>.</p></div><div id="cls.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Individuals with CLS who experience SIDAs should be protected as much as possible from being startled and/or from falls.</p></div><div id="cls.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#cls.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cls.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cls.Genetic_Counseling"><h2 id="_cls_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cls.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Coffin-Lowry syndrome (CLS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><p>Approximately 70%-80% of probands have no family history of CLS, and 20%-30% have more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member [<a class="bk_pop" href="#cls.REF.delaunoy.2001.103">Delaunoy et al 2001</a>]. The high incidence of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., CLS in a single individual in a family) can be attributed to genetic selection that occurs against <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females who are intellectually disabled [<a class="bk_pop" href="#cls.REF.jacquot.1998a.1631">Jacquot et al 1998a</a>].</p></div><div id="cls.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Male:</div><ul><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>. About 70%-80% of affected males represent simplex cases, roughly 2/3 of which occur <i>de novo</i> [<a class="bk_pop" href="#cls.REF.pereira.2010.627">Pereira et al 2010</a>].</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a>. Note: If a woman has more than one affected child and no other affected relatives and if the <i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#cls.REF.jacquot.1998b.578">Jacquot et al 1998b</a>, <a class="bk_pop" href="#cls.REF.horn.2001.881">Horn et al 2001</a>].</div></li><li class="half_rhythm"><div>Recommendations for the mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> include examination for signs of CLS (e.g., coarse facial features, full lips, and/or tapering fingers) and, if a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the proband, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li></ul></li><li class="half_rhythm"><div>Female:</div><ul><li class="half_rhythm"><div>A female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have inherited the <i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from her mother or, in the theoretic case of paternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, her father.</div></li><li class="half_rhythm"><div>Recommendations for the mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> include examination for signs of CLS and, if a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the proband, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li></ul></li><li class="half_rhythm"><div>Detailed evaluation of the parents and review of the extended family history may help distinguish probands with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from those with an inherited pathogenic variant. Molecular genetic testing of the mother can typically determine if the pathogenic variant was inherited.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the mother. Theoretically, the genetic status of the father (if the proband is female) could be a factor in risk to sibs in the event of paternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for an <i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%:</div><ul><li class="half_rhythm"><div>Male sibs who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; female sibs who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and at high risk for at least some developmental delay and mild physical signs of CLS.</div></li><li class="half_rhythm"><div>As expected with random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>, a mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> woman may have a severely affected daughter.</div></li><li class="half_rhythm"><div>Heterozygous females may show mild-to-moderate skewing of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> that does not correlate with IQ [<a class="bk_pop" href="#cls.REF.simensen.2002.299">Simensen et al 2002</a>].</div></li></ul></li><li class="half_rhythm"><div>In the absence of any physical signs or intellectual impairment, the mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with no known family history of CLS is probably at low risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>.</div></li><li class="half_rhythm"><div>Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has been demonstrated in this condition. Thus, even if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has not been identified in the mother's DNA, sibs of the proband are still at increased risk of inheriting the pathogenic variant [<a class="bk_pop" href="#cls.REF.jacquot.1998b.578">Jacquot et al 1998b</a>, <a class="bk_pop" href="#cls.REF.horn.2001.881">Horn et al 2001</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Males and severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females with CLS typically do not reproduce.</div></li><li class="half_rhythm"><div>Women with CLS have a 50% chance of transmitting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to each child; sons who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; daughters will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and at high risk for at least some degree of developmental delay and mild physical signs of CLS.</div></li></ul><p><b>Other family members.</b> If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is found to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, her female family members may be at risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (asymptomatic or symptomatic); and her male family members may be at risk of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> depending on their genetic relationship to the proband.</p></div><div id="cls.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Note: (1) Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder will have a range of clinical manifestations (see <a href="#cls.Clinical_Description">Clinical Description</a>). (2) Identification of female heterozygotes requires either (a) prior identification of the <i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family; or (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and if no pathogenic variant is identified, by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div><div id="cls.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Specific counseling issues</b></p><ul><li class="half_rhythm"><div>Significant social resources may be required to support developmentally delayed women with CLS and their families with respect to reproductive choices and child care.</div></li><li class="half_rhythm"><div>Caution should be used in interpreting the results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of a mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with no known family history of CLS (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case) in whom a <i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified. Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has been observed; thus, it is appropriate to offer prenatal testing even when the pathogenic variant identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> offspring is not detected in maternal leukocyte DNA.</div></li></ul><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young women who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, or at risk of being heterozygous.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cls.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>RPS6KA3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="cls.Resources"><h2 id="_cls_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Coffin-Lowry Syndrome Foundation</b></div><div><b>Phone:</b> 425-427-0939</div><div><b>Email:</b> CoffinLowry@gmail.com</div><div><a href="http://clsf.info/default.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CLSF</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Coffin-Lowry-Syndrome-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Coffin Lowry Syndrome Information Page</a></div></li></ul></div><div id="cls.Molecular_Genetics"><h2 id="_cls_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cls.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Coffin-Lowry Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1346/table/cls.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cls.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cls.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cls.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cls.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cls.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cls.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cls.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cls.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6197" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RPS6KA3</i></a></td><td headers="hd_b_cls.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6197" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp22<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_cls.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51812" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ribosomal protein S6 kinase alpha-3</a></td><td headers="hd_b_cls.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/RPS6KA3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RPS6KA3 @ LOVD</a></td><td headers="hd_b_cls.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RPS6KA3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RPS6KA3</a></td><td headers="hd_b_cls.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RPS6KA3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RPS6KA3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cls.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cls.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Coffin-Lowry Syndrome (<a href="/omim/300075,303600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1346/table/cls.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cls.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300075" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300075</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 3; RPS6KA3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/303600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">303600</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COFFIN-LOWRY SYNDROME; CLS</td></tr></tbody></table></div></div><div id="cls.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>RPS6KA3</i>
<i>(RSK2</i>), the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> associated with CLS, encodes a growth factor-regulated serine/threonine kinase that is a member of the Ras signaling cascade. Humans have four closely related RPS6KA (RSK) genes; each gene has two non-identical kinase catalytic domains, both of which are required for maximal activity [<a class="bk_pop" href="#cls.REF.yntema.1999.332">Yntema et al 1999</a>, <a class="bk_pop" href="#cls.REF.yang.2004.387">Yang et al 2004</a>]. Members of the <i>RSK</i> family participate in cellular events such as proliferation and differentiation.</p><p><b>Gene structure.</b> The <i>RPS6KA3</i> transcript <a href="/nuccore/NM_004586.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004586.2</a> comprises 22 exons; it is named for ribosomal S6 kinase (alternate name: <i>RSK2</i>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1346/#cls.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants in <i>RPS6KA3</i> are distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> with no evidence of clustering associated with a specific <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>In the largest study to date (250 individuals), 71 pathogenic variants were found in 86 unrelated families. Almost 60% caused or predicted protein truncation; 38% were <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, 20% <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, 18% errors of <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>, and 21% intragenic deletions or insertions [<a class="bk_pop" href="#cls.REF.delaunoy.2001.103">Delaunoy et al 2001</a>].</p><p>A smaller study of 106 unrelated individuals with suspected CLS found 28 pathogenic variants (26%). Of the 28 pathogenic variants, 60% caused or predicted protein truncation; 36% were <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, 21% <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, 11% errors of <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>, and 32% intragenic deletions or insertions [Abidi &#x00026; Schwartz, unpublished].</p><p>Splice site pathogenic variants and an <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> LINE-1 <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> that disrupts the normal function of the protein have been reported [<a class="bk_pop" href="#cls.REF.zeniou.2002.2929">Zeniou et al 2002</a>, <a class="bk_pop" href="#cls.REF.mart_nezgaray.2003.491">Mart&#x000ed;nez-Garay et al 2003</a>, <a class="bk_pop" href="#cls.REF.zeniou.2004.1214">Zeniou et al 2004</a>]. (For more information, see <a href="/books/NBK1346/#cls.molgen.TA">Table A</a>.)</p><p>Recently, <a class="bk_pop" href="#cls.REF.schneider.2013.150">Schneider et al [2013]</a> have identified a deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that results in an aberrant protein. This finding warrants analysis for pathogenic variants at the RNA level in all individuals with a highly suggestive clinical diagnosis of CLS and in whom <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> screening has failed to detect a pathogenic variant.</p><p>Full- and partial-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> duplications have been reported. <a class="bk_pop" href="#cls.REF.matsumoto.2013.755">Matsumoto et al [2013]</a> report a microduplication including the entire <i>RPS6KA3</i> in a family with mild ID, ADHD, localization-related epilepsy, and pervasive developmental disorder (PDD). <a class="bk_pop" href="#cls.REF.marques_pereira.2007.541">Marques Pereira et al [2007]</a> report an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a>, tandem multiexon <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> in an individual with CLS. Given the high frequency of Alu sequences within the gene, they suggest that these may be a relatively common event; however, additional studies are needed.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Ribosomal protein S6 kinase alpha-3 (RPS6KA3) is involved in kinase activation in a number of pathways including ras-MAPK, protein kinase C, and adenyl cyclase [<a class="bk_pop" href="#cls.REF.harum.2001.207">Harum et al 2001</a>, <a class="bk_pop" href="#cls.REF.pereira.2010.627">Pereira et al 2010</a>]. RPS6KA3 regulates neurite formation [<a class="bk_pop" href="#cls.REF.ammar.2013.19470">Ammar et al 2013</a>], mediates activation of PLD1 to produce the lipids required for exocytosis [<a class="bk_pop" href="#cls.REF.zenioumeyer.2008.8434">Zeniou-Meyer et al 2008</a>, <a class="bk_pop" href="#cls.REF.zenioumeyer.2009.201">Zeniou-Meyer et al 2009</a>], and regulates the release of neurotransmitters [<a class="bk_pop" href="#cls.REF.zenioumeyer.2010.1401">Zeniou-Meyer et al 2010</a>].</p><p>Association of <i>RPS6KA3</i> with nonsyndromic XLMR (MRX19; see <a href="#cls.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>) as well as CLS indicates that the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is critical for cognitive function. <i>RPS6KA3</i> expression shows both temporal and spatial restriction in human embryogenesis, with homogeneous brain expression from the telencephalon to the rhombencephalon at nine weeks' gestation [<a class="bk_pop" href="#cls.REF.guimiot.2004.111">Guimiot et al 2004</a>]. <i>RPS6KA3</i> has also been shown to activate CREB (<i>c</i>AMP <i>r</i>esponse <i>e</i>lement <i>b</i>inding protein), which is involved in neuronal survival and conversion from short- to long-term memory [<a class="bk_pop" href="#cls.REF.harum.2001.207">Harum et al 2001</a>].</p><p>RPS6KA3 also plays an important role in maintaining <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> stability by mediating cell cycle progression and DNA repair [<a class="bk_pop" href="#cls.REF.lim.2013.e74334">Lim et al 2013</a>]. Through the MAPK/RSK pathway and the epidermal growth factor (EGF)-stimulated phosphorylation of histone H3, it appears to play a role in stimulation of the cell cycle between G0 and G1.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>RPS6KA3</i> give rise to both CLS and nonsyndromic XLMR. The pathogenic variants in individuals with CLS result in the loss of kinase activity of the gene product. However, the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> associated with MRX19 occurs outside the kinase domains and results in reduction of RPS6KA3 activity, suggesting that the brain is more sensitive to levels of RPS6KA3 activity than are the other organ systems <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> in CLS.</p><p>In a sample of seven individuals, <a class="bk_pop" href="#cls.REF.harum.2001.207">Harum et al [2001]</a> showed a correlation between IQ and the degree of attenuation of the RPS6KA3-mediated CREBtide phosphorylation response in lymphoblasts.</p><p><a class="bk_pop" href="#cls.REF.yang.2004.387">Yang et al [2004]</a> proposed that lack of phosphorylation of ATF4 by RPS6KA3 may interrupt the normal regulatory role of ATF4 in osteoblast differentiation, accounting for some of the bone anomalies seen in CLS, as well as possibly explaining the progressive nature of the kyphoscoliosis</p></div></div><div id="cls.References"><h2 id="_cls_References_">References</h2><div id="cls.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cls.REF.ammar.2013.19470">Ammar MR, Humeau Y, Hanauer A, Nieswandt B, Bader MF, Vitale N. The Coffin-Lowry syndrome-associated protein RSK2 regulates neurite outgrowth through phosphorylation of phospholipase D1 (PLD1) and synthesis of phosphatidic acid. <span><span class="ref-journal">J Neurosci. </span>2013;<span class="ref-vol">33</span>:19470–9.</span> [<a href="/pmc/articles/PMC6618760/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6618760</span></a>] [<a href="/pubmed/24336713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24336713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.arslan.2014.196">Arslan EA, Ceylander S, Turanli G. Stimulus-induced myoclonus treated effectively with clonazepam in genetically confirmed Coffin-Lowry syndrome. <span><span class="ref-journal">Epilepsy Behav Case Rep. </span>2014;<span class="ref-vol">2</span>:196–8.</span> [<a href="/pmc/articles/PMC4308038/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4308038</span></a>] [<a href="/pubmed/25667906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25667906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.coffin.2003.187">Coffin GS. Postmortem findings in the Coffin-Lowry syndrome. <span><span class="ref-journal">Genet Med. </span>2003;<span class="ref-vol">5</span>:187–93.</span> [<a href="/pubmed/12792428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12792428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.concannon.2002.e41">Concannon N, Hegarty AM, Stallings RL, Reardon W. Coffin-Lowry phenotype in a patient with a complex chromosome rearrangement. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:e41.</span> [<a href="/pmc/articles/PMC1735192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735192</span></a>] [<a href="/pubmed/12161608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12161608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.crow.1998.94">Crow YJ, Zuberi SM, McWilliam R, Tolmie JL, Hollman A, Pohl K, Stephenson JB. "Cataplexy" and muscle ultrasound abnormalities in Coffin-Lowry syndrome. <span><span class="ref-journal">J Med Genet. </span>1998;<span class="ref-vol">35</span>:94–8.</span> [<a href="/pmc/articles/PMC1051210/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051210</span></a>] [<a href="/pubmed/9507386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9507386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.delaunoy.2001.103">Delaunoy J, Abidi F, Zeniou M, Jacquot S, Merienne K, Pannetier S, Schmitt M, Schwartz C, Hanauer A. Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. <span><span class="ref-journal">Hum Mutat. </span>2001;<span class="ref-vol">17</span>:103–16.</span> [<a href="/pubmed/11180593" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11180593</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.delaunoy.2006.161">Delaunoy JP, Dubos A, Marques Pereira P, Hanauer A. Identification of novel mutations in the RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. <span><span class="ref-journal">Clin Genet. </span>2006;<span class="ref-vol">70</span>:161–6.</span> [<a href="/pubmed/16879200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16879200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.facher.2004.176">Facher JJ, Regier EJ, Jacobs GH, Siwik E, Delaunoy JP, Robin NH. Cardiomyopathy in Coffin-Lowry syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">128A</span>:176–8.</span> [<a href="/pubmed/15214012" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15214012</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.field.2006.509">Field M, Tarpey P, Boyle J, Edkins S, Goodship J, Luo Y, Moon J, Teague J, Stratton MR, Futreal PA, Wooster R, Raymond FL, Turner G. Mutations in the RSK2 (RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation. <span><span class="ref-journal">Clin Genet. </span>2006;<span class="ref-vol">70</span>:509–15.</span> [<a href="/pmc/articles/PMC2714973/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2714973</span></a>] [<a href="/pubmed/17100996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17100996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.fryssira.2002.405">Fryssira H, Kountoupi S, Delaunoy JP, Thomaidis L. A female with Coffin-Lowry syndrome and "cataplexy.". <span><span class="ref-journal">Genet Couns. </span>2002;<span class="ref-vol">13</span>:405–9.</span> [<a href="/pubmed/12558110" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12558110</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.graham.1998.145">Graham JM Jr, Tackels D, Dibbern K, Superneau D, Rogers C, Corning K, Schwartz CE. FG syndrome: report of three new families with linkage to Xq12-q22.1. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">80</span>:145–56.</span> [<a href="/pubmed/9805132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9805132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.guimiot.2004.111">Guimiot F, Delezoide AL, Hanauer A, Simonneau M. Expression of the RSK2 gene during early human development. <span><span class="ref-journal">Gene Expr Patterns. </span>2004;<span class="ref-vol">4</span>:111–4.</span> [<a href="/pubmed/14678837" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14678837</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.hahn.2012.335">Hahn JS, Hanauer A. Stimulus-induced drop episodes in Coffin-Lowry syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:335–7.</span> [<a href="/pubmed/22490425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22490425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.hanauer.2002.705">Hanauer A, Young ID. Coffin-Lowry syndrome: clinical and molecular features. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:705–13.</span> [<a href="/pmc/articles/PMC1734994/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734994</span></a>] [<a href="/pubmed/12362025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12362025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.harum.2001.207">Harum KH, Alemi L, Johnston MV. Cognitive impairment in Coffin-Lowry syndrome correlates with reduced RSK2 activation. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">56</span>:207–14.</span> [<a href="/pubmed/11160957" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11160957</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.havaligi.2007.373">Havaligi N, Matadeen-Ali C, Khurana DS, Marks H, Kothare SV. Treatment of drop attacks in Coffin-Lowry syndrome with the use of sodium oxybate. <span><span class="ref-journal">Pediatr Neurol. </span>2007;<span class="ref-vol">37</span>:373–4.</span> [<a href="/pubmed/17950427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17950427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.herrerasoto.2007.85">Herrera-Soto JA, Santiago-Cornier A, Segal LS, Ramirez N, Tamai J. The musculoskeletal manifestations of the Coffin-Lowry syndrome. <span><span class="ref-journal">J Pediatr Orthop. </span>2007;<span class="ref-vol">27</span>:85–9.</span> [<a href="/pubmed/17195803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17195803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.horn.2001.881">Horn D, Delaunoy JP, Kunze J. Prenatal diagnosis in Coffin-Lowry syndrome demonstrates germinal mosaicism confirmed by mutation analysis. <span><span class="ref-journal">Prenat Diagn. </span>2001;<span class="ref-vol">21</span>:881–4.</span> [<a href="/pubmed/11746134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11746134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.hunter.2010">Hunter AG. Coffin-Lowry syndrome. In: Cassidy S, Allanson J, eds. <em>Management of Genetic Syndromes</em>. 3 ed. Hoboken, NJ: Wiley-Liss; 2010:127-38.</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.hunter.2002.345">Hunter AG. Coffin-Lowry syndrome: a 20-year follow-up and review of long-term outcomes. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">111</span>:345–55.</span> [<a href="/pubmed/12210291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12210291</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.imataka.2016.498">Imataka G, Nakajima I, Goto K, Konno W, Hirabayashi H, Arisaka O. Drop episodes improved after tracheostomy: a case of Coffin-Lowry syndrome associated with obstructive sleep apnea syndrome. <span><span class="ref-journal">Eur Rev Med Pharmacol Sci. </span>2016;<span class="ref-vol">20</span>:498–501.</span> [<a href="/pubmed/26914125" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26914125</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.jacquot.1998a.1631">Jacquot S, Merienne K, De Cesare D, Pannetier S, Mandel JL, Sassone-Corsi P, Hanauer A. Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations. <span><span class="ref-journal">Am J Hum Genet. </span>1998a;<span class="ref-vol">63</span>:1631–40.</span> [<a href="/pmc/articles/PMC1377634/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377634</span></a>] [<a href="/pubmed/9837815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9837815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.jacquot.1998b.578">Jacquot S, Merienne K, Pannetier S, Blumenfeld S, Schinzel A, Hanauer A. Germline mosaicism in Coffin-Lowry syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>1998b;<span class="ref-vol">6</span>:578–82.</span> [<a href="/pubmed/9887375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9887375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.jacquot.2002.2">Jacquot S, Zeniou M, Touraine R, Hanauer A. X-linked Coffin-Lowry syndrome (CLS, MIM 303600, RPS6KA3 gene, protein product known under various names: pp90(rsk2), RSK2, ISPK, MAPKAP1). <span><span class="ref-journal">Eur J Hum Genet. </span>2002;<span class="ref-vol">10</span>:2–5.</span> [<a href="/pubmed/11896450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11896450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.jurkiewicz.2010.268">Jurkiewicz D, Jezela-Stanek A, Ciara E, Piekutowska-Abramczuk D, Kugaudo M, Gajdulewicz M, Chrzanowska K, Popowska E, Krajewska-Walasek M. Four novel RSK2 mutations in females with Coffin-Lowry syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2010;<span class="ref-vol">53</span>:268–73.</span> [<a href="/pubmed/20637903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20637903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.kesler.2007.143">Kesler SR, Simensen RJ, Voeller K, Abidi F, Stevenson RE, Schwartz CE, Reiss AL. Altered neurodevelopment associated with mutations of RSK2: a morphometric MRI study of Coffin-Lowry syndrome. <span><span class="ref-journal">Neurogenetics. </span>2007;<span class="ref-vol">8</span>:143–7.</span> [<a href="/pmc/articles/PMC3055244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3055244</span></a>] [<a href="/pubmed/17318637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17318637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.kondoh.1998.59">Kondoh T, Matsumoto T, Ochi M, Sukegawa K, Tsuji Y. New radiological finding by magnetic resonance imaging examination of the brain in Coffin-Lowry syndrome. <span><span class="ref-journal">J Hum Genet. </span>1998;<span class="ref-vol">43</span>:59–61.</span> [<a href="/pubmed/9610000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9610000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.lim.2013.e74334">Lim HC, Xie L, Zhang W, Li R, Chen ZC, Wu GZ, Cui SS, Tan EK, Zeng L. Ribosomal S6 Kinase 2 (RSK2) maintains genomic stability by activating the Atm/p53-dependent DNA damage pathway. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e74334.</span> [<a href="/pmc/articles/PMC3781089/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3781089</span></a>] [<a href="/pubmed/24086335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24086335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.lower.2002.661">Lower KM, Turner G, Kerr BA, Mathews KD, Shaw MA, Gedeon AK, Schelley S, Hoyme HE, White SM, Delatycki MB, Lampe AK, Clayton-Smith J, Stewart H, van Ravenswaay CM, de Vries BB, Cox B, Grompe M, Ross S, Thomas P, Mulley JC, Gecz J. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">32</span>:661–5.</span> [<a href="/pubmed/12415272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12415272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.lowry.1971.496">Lowry B, Miller JR, Fraser FC. A new dominant gene mental retardation syndrome. Association with small stature, tapering fingers, characteristic facies, and possible hydrocephalus. <span><span class="ref-journal">Am J Dis Child. </span>1971;<span class="ref-vol">121</span>:496–500.</span> [<a href="/pubmed/5581017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5581017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.manouvrierhanu.1999.775">Manouvrier-Hanu S, Amiel J, Jacquot S, Merienne K, Moerman A, Coeslier A, Labarriere F, Vallee L, Croquette MF, Hanauer A. Unreported RSK2 missense mutation in two male sibs with an unusually mild form of Coffin-Lowry syndrome. <span><span class="ref-journal">J Med Genet. </span>1999;<span class="ref-vol">36</span>:775–8.</span> [<a href="/pmc/articles/PMC1734232/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734232</span></a>] [<a href="/pubmed/10528858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10528858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.marques_pereira.2007.541">Marques Pereira P, Heron D, Hanauer A. The first large duplication of the RSK2 gene identified in a Coffin-Lowry syndrome patient. <span><span class="ref-journal">Hum Genet. </span>2007;<span class="ref-vol">122</span>:541–3.</span> [<a href="/pubmed/17717706" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17717706</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.mart_nezgaray.2003.491">Mart&#x000ed;nez-Garay I, Ballesta MJ, Oltra S, Orellana C, Palomeque A, Molto MD, Prieto F, Martinez F. Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome. <span><span class="ref-journal">Clin Genet. </span>2003;<span class="ref-vol">64</span>:491–6.</span> [<a href="/pubmed/14986828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14986828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.martinez.2011.3030">Martinez HR, Niu MC, Sutton VR, Pignatelli R, Vatta M, Jefferies JL. Coffin-Lowry syndrome and left ventricular noncompaction cardiomyopathy with a restrictive pattern. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:3030–4.</span> [<a href="/pubmed/22009732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22009732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.massin.1999.468">Massin MM, Radermecker MA, Verloes A, Jacquot S, Grenade T. Cardiac involvement in Coffin-Lowry syndrome. <span><span class="ref-journal">Acta Paediatr. </span>1999;<span class="ref-vol">88</span>:468–70.</span> [<a href="/pubmed/10342551" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10342551</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.matsumoto.2013.755">Matsumoto A, Kuwajima M, Miyake K, Kojima K, Nakashima N, Jimbo EF, Kubota T, Momoi MY, Yamagata T. An Xp22.12 microduplication including RPS6KA3 identified in a family with variably affected intellectual and behavioral disabilities. <span><span class="ref-journal">J Hum Genet. </span>2013;<span class="ref-vol">58</span>:755–7.</span> [<a href="/pubmed/23985797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23985797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.mccandless.2000.93">McCandless SE, Schwartz S, Morrison S, Garlapati K, Robin NH. Adult with an interstitial deletion of chromosome 10 [del(10)(q25. 1q25.3)]: overlap with Coffin-Lowry syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">95</span>:93–8.</span> [<a href="/pubmed/11078556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11078556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.merienne.1999.13">Merienne K, Jacquot S, Pannetier S, Zeniou M, Bankier A, Gecz J, Mandel JL, Mulley J, Sassone-Corsi P, Hanauer A. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">22</span>:13–4.</span> [<a href="/pubmed/10319851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10319851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.micheli.2007.35">Micheli V, Sestini S, Parri V, Fichera M, Romano C, Ariani F, Longo I, Mari F, Bruttini M, Renieri A, Meloni I. RSK2 enzymatic assay as a second level diagnostic tool in Coffin-Lowry syndrome. <span><span class="ref-journal">Clin Chim Acta. </span>2007;<span class="ref-vol">384</span>:35–40.</span> [<a href="/pubmed/17586481" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17586481</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.nakamura.1998.148">Nakamura M, Yamagata T, Momoi MY, Yamazaki T. Drop episodes in Coffin-Lowry syndrome: exaggerated startle responses treated with clonazepam. <span><span class="ref-journal">Pediatr Neurol. </span>1998;<span class="ref-vol">19</span>:148–50.</span> [<a href="/pubmed/9744638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9744638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.nakamura.2005.114">Nakamura M, Yamagata T, Mori M, Momoi MY. RSK2 gene mutations in Coffin-Lowry syndrome with drop episodes. <span><span class="ref-journal">Brain Dev. </span>2005;<span class="ref-vol">27</span>:114–7.</span> [<a href="/pubmed/15668050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15668050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.nelson.2003.e197">Nelson GB, Hahn JS. Stimulus-induced drop episodes in Coffin-Lowry syndrome. <span><span class="ref-journal">Pediatrics. </span>2003;<span class="ref-vol">111</span>:e197–202.</span> [<a href="/pubmed/12612271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12612271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.oriordan.2006.109">O'Riordan S, Patton M, Schon F. Treatment of drop episodes in Coffin-Lowry syndrome. <span><span class="ref-journal">J Neurol. </span>2006;<span class="ref-vol">253</span>:109–10.</span> [<a href="/pubmed/16021355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16021355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.pereira.2010.627">Pereira PM, Schneider A, Pannetier S, Heron D, Hanauer A. Coffin-Lowry syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2010;<span class="ref-vol">18</span>:627–33.</span> [<a href="/pmc/articles/PMC2987346/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2987346</span></a>] [<a href="/pubmed/19888300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19888300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.plomp.1995.259">Plomp AS, De Die-Smulders CEM, Meinecke P, Ypma-Verhulst JM, Lissone DA, Fryns JP. The Coffin-Lowry syndrome at different ages and symptoms in female carriers. <span><span class="ref-journal">Genet Couns. </span>1995;<span class="ref-vol">6</span>:259–68.</span> [<a href="/pubmed/8588856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8588856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.rojnueangnit.2014.516">Rojnueangnit K, Jones JR, Basehore MJ, Robin NH. Classic phenotype of Coffin-Lowry syndrome in a female with stimulus-induced drop episodes and a genotype with preserved N-terminal kinase domain. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:516–21.</span> [<a href="/pubmed/24311527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24311527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.rosanowski.1998.224">Rosanowski F, Hoppe U, Proschel U, Eysholdt U. Late-onset sensorineural hearing loss in Coffin-Lowry syndrome. <span><span class="ref-journal">ORL J Otorhinolaryngol Relat Spec. </span>1998;<span class="ref-vol">60</span>:224–6.</span> [<a href="/pubmed/9646311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9646311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.schneider.2013.150">Schneider A, Maas SM, Hennekam RC, Hanauer A. Identification of the first deep intronic mutation in the RPS6KA3 gene in a patient with a severe form of Coffin-Lowry syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2013;<span class="ref-vol">56</span>:150–2.</span> [<a href="/pubmed/23261961" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23261961</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.simensen.2002.299">Simensen RJ, Abidi F, Collins JS, Schwartz CE, Stevenson RE. Cognitive function in Coffin-Lowry syndrome. <span><span class="ref-journal">Clin Genet. </span>2002;<span class="ref-vol">61</span>:299–304.</span> [<a href="/pubmed/12030896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12030896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.stephenson.2005.108">Stephenson JB, Hoffman MC, Russell AJ, Falconer J, Beach RC, Tolmie JL, McWilliam RC, Zuberi SM. The movement disorders of Coffin-Lowry syndrome. <span><span class="ref-journal">Brain Dev. </span>2005;<span class="ref-vol">27</span>:108–13.</span> [<a href="/pubmed/15668049" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15668049</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.tos.2015.47">Tos T, Alp MY, Aksoy A, Ceylaner S, Hanauer A. A familial case of Coffin-Lowry syndrome caused by RPS6KA3 C.898C&#x0003e;T mutation associated with multiple abnormal brain imaging findings. <span><span class="ref-journal">Genet Couns. </span>2015;<span class="ref-vol">26</span>:47–52.</span> [<a href="/pubmed/26043507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26043507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.touraine.2002.179">Touraine R-L, Zeniou M, Hanauer A. A syndromic form of X-linked mental retardation: the Coffin-Lowry syndrome. <span><span class="ref-journal">Eur J Pediatr. </span>2002;<span class="ref-vol">161</span>:179–87.</span> [<a href="/pubmed/12014383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12014383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.upadia.2017.1087">Upadia J, Oakes J, Hamm A, Hurst AC, Robin NH. Foramen magnum compression in Coffin-Lowry syndrome: a case report. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:1087–9.</span> [<a href="/pubmed/28190284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28190284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.valdovinos.2002.268">Valdovinos MG, Napolitano DA, Zarcone JR, Hellings JA, Williams DC, Schroeder SR. Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions. <span><span class="ref-journal">Exp Clin Psychopharmacol. </span>2002;<span class="ref-vol">10</span>:268–75.</span> [<a href="/pubmed/12233987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12233987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.wang.2006.1274">Wang Y, Martinez JE, Wilson GL, He XY, Tuck-Muller CM, Maertens P, Wertelecki W, Chen TJ. A novel RSK2 (RPS6KA3) gene mutation associated with abnormal brain MRI findings in a family with Coffin-Lowry syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1274–9.</span> [<a href="/pubmed/16691578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16691578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.yang.2004.387">Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. <span><span class="ref-journal">Cell. </span>2004;<span class="ref-vol">117</span>:387–98.</span> [<a href="/pubmed/15109498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15109498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.yntema.1999.332">Yntema HG, van den Helm B, Kissing J, van Duijnhoven G, Poppelaars F, Chelly J, Moraine C, Fryns JP, Hamel BC, Heilbronner H, Pander HJ, Brunner HG, Ropers HH, Cremers FP, van Bokhoven H. A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. <span><span class="ref-journal">Genomics. </span>1999;<span class="ref-vol">62</span>:332–43.</span> [<a href="/pubmed/10644430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10644430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.young.1988.344">Young ID. The Coffin-Lowry syndrome. <span><span class="ref-journal">J Med Genet. </span>1988;<span class="ref-vol">25</span>:344–8.</span> [<a href="/pmc/articles/PMC1050463/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050463</span></a>] [<a href="/pubmed/3290491" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3290491</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.zeniou.2002.2929">Zeniou M, Ding T, Trivier E, Hanauer A. Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:2929–40.</span> [<a href="/pubmed/12393804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12393804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.zeniou.2004.1214">Zeniou M, Gattoni R, Hanauer A, Stevenin J. Delineation of the mechanisms of aberrant splicing caused by two unusual intronic mutations in the RSK2 gene involved in Coffin-Lowry syndrome. <span><span class="ref-journal">Nucleic Acids Res. </span>2004;<span class="ref-vol">32</span>:1214–23.</span> [<a href="/pmc/articles/PMC373406/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC373406</span></a>] [<a href="/pubmed/14973203" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14973203</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.zenioumeyer.2009.201">Zeniou-Meyer M, B&#x000e9;gl&#x000e9; A, Bader MF, Vitale N. The Coffin-Lowry syndrome-associated protein RSK2 controls neuroendocrine secretion through the regulation of phospholipase D1 at the exocytotic sites. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2009;<span class="ref-vol">1152</span>:201–8.</span> [<a href="/pubmed/19161391" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19161391</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.zenioumeyer.2010.1401">Zeniou-Meyer M, Gambino F, Ammar MR, Humeau Y, Vitale N. The Coffin-Lowry syndrome-associated protein RSK2 and neurosecretion. <span><span class="ref-journal">Cell Mol Neurobiol. </span>2010;<span class="ref-vol">30</span>:1401–6.</span> [<a href="/pubmed/21061166" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21061166</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cls.REF.zenioumeyer.2008.8434">Zeniou-Meyer M, Liu Y, B&#x000e9;gl&#x000e9; A, Olanich ME, Hanauer A, Becherer U, Rettig J, Bader MF, Vitale N. The Coffin-Lowry syndrome-associated protein RSK2 is implicated in calcium-regulated exocytosis through the regulation of PLD1. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2008;<span class="ref-vol">105</span>:8434–9.</span> [<a href="/pmc/articles/PMC2448854/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2448854</span></a>] [<a href="/pubmed/18550821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18550821</span></a>]</div></li></ul></div></div><div id="cls.Chapter_Notes"><h2 id="_cls_Chapter_Notes_">Chapter Notes</h2><div id="cls.Author_History"><h3>Author History</h3><p>Fatima E Abidi, PhD, DABMGG (2002-present)<br />Alisdair GW Hunter, MD; University of Ottawa (2002-2014)<br />R Curtis Rogers, MD (2014-present)<br />Charles E Schwartz, PhD; Greenwood Genetics Center (2002-2009)</p></div><div id="cls.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 February 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 March 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 January 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 August 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>31 August 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 December 2004 (cd) Revision: change in <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> availability</div></li><li class="half_rhythm"><div>28 June 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 July 2002 (me) Review posted live</div></li><li class="half_rhythm"><div>24 January 2002 (ah) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1346</span><span class="label">PMID: <a href="/pubmed/20301520" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301520</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cockayne/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/coffin-siris/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1346&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1346/?report=reader">PubReader</a></li><li><a href="/books/NBK1346/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1346" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1346" style="display:none" title="Cite this Page"><div class="bk_tt">Rogers RC, Abidi FE. Coffin-Lowry Syndrome. 2002 Jul 16 [Updated 2018 Feb 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1346/pdf/Bookshelf_NBK1346.pdf">PDF version of this page</a> (658K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cls.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cls.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cls.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cls.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cls.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cls.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cls.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cls.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cls.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cls.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cls.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6197[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RPS6KA3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1459312" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1459312" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1459312" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1459312" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301398" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301567" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robertson S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301298" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Darras BT, Urion DK, Ghosh PS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301520" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301520" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041a8975f66d18aab297be">Coffin-Lowry Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Coffin-Lowry Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:27:21-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88079DE041597100000000023C00D0&amp;ncbi_session=CE88079DE041A881_0572SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1346%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1346&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1346/&amp;ncbi_pagename=Coffin-Lowry Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88079DE041A881_0572SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>